0 Evaluaciones

ID

42351

Descripción

Intralesional Rituximab for the Treatment of Conjunctival Indolent Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT01514344

Link

https://clinicaltrials.gov/show/NCT01514344

Palabras clave

  1. 22/6/21 22/6/21 -
Titular de derechos de autor

Andres J. M. Ferreri

Subido en

22 de junio de 2021

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :


    Sin comentarios

    Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

    Eligibility Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma NCT01514344

    Eligibility Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma NCT01514344

    Inclusion Criteria
    Descripción

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    histological diagnosis of cd20+ b cell lymphoma subtypes: marginal zone lymphoma, grade 1-2 follicular lymphoma, plasmocytic lymphoma, small lymphocyte lymphoma
    Descripción

    Marginal zone lymphoma | Grade 1-2 follicular lymphoma | Myeloma | Small lymphocyte lymphoma

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1,1]
    C1367654
    UMLS CUI [1,2]
    C0679557
    UMLS CUI [1,3]
    C0054946
    UMLS CUI [2,1]
    C0024301
    UMLS CUI [2,2]
    C0441800
    UMLS CUI [2,3]
    C0679557
    UMLS CUI [2,4]
    C0054946
    UMLS CUI [3,1]
    C0026764
    UMLS CUI [3,2]
    C0679557
    UMLS CUI [3,3]
    C0054946
    UMLS CUI [4,1]
    C0855095
    UMLS CUI [4,2]
    C0679557
    UMLS CUI [4,3]
    C0054946
    conjunctival localization alone (1ea stage; mono- or bilateral)
    Descripción

    Conjunctival localization, stage, monolateral or bilateral

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1,1]
    C0475264
    UMLS CUI [1,2]
    C0009758
    UMLS CUI [1,3]
    C0443288
    UMLS CUI [1,4]
    C1300072
    UMLS CUI [1,5]
    C0238767
    UMLS CUI [2,1]
    C0475264
    UMLS CUI [2,2]
    C0009758
    UMLS CUI [2,3]
    C0443288
    UMLS CUI [2,4]
    C1300072
    UMLS CUI [2,5]
    C0205092
    at least one measurable lesion
    Descripción

    At least one measurable lesion

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1,1]
    C1513041
    UMLS CUI [1,2]
    C1265611
    age >/= 18 years
    Descripción

    Age

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0001779
    ecog-ps </=3
    Descripción

    Ecog-ps =<3

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C1520224
    hiv 1-2 negativity
    Descripción

    HIV negative

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0481430
    at least one previous treatment (antibiotic or rituximab)
    Descripción

    At least one previous treatment with antibiotic or rituximab

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1,1]
    C0393022
    UMLS CUI [1,2]
    C2114510
    UMLS CUI [1,3]
    C1524031
    UMLS CUI [2,1]
    C0338237
    UMLS CUI [2,2]
    C2114510
    UMLS CUI [2,3]
    C1524031
    Exclusion Criteria
    Descripción

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    concomitant conventional (chemo-, radiation, immuno-), experimental (antibiotic) or corticosteroid anticancer therapy
    Descripción

    Concomitant chemotherapy | Concomitant radiation | Concomitant immunotherapy | Concomitant antibiotic therapy | Concomitant corticosteroid therapy

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1,1]
    C1707479
    UMLS CUI [1,2]
    C3665472
    UMLS CUI [2,1]
    C1707479
    UMLS CUI [2,2]
    C1522449
    UMLS CUI [3,1]
    C1707479
    UMLS CUI [3,2]
    C0021083
    UMLS CUI [4,1]
    C1707479
    UMLS CUI [4,2]
    C0338237
    UMLS CUI [5,1]
    C1707479
    UMLS CUI [5,2]
    C0149783
    known allergy to rituximab
    Descripción

    Allergy to rituximab

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1,1]
    C0020517
    UMLS CUI [1,2]
    C0393022
    systemic symptoms
    Descripción

    Systemic symptoms

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C2039684
    concurrent diagnosis of pemphigus
    Descripción

    Pemphigus as a comorbidity

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1,1]
    C0030807
    UMLS CUI [1,2]
    C0009488
    postsurgical conjunctival scars
    Descripción

    Postsurgical scars in conjuctival location

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1,1]
    C0334150
    UMLS CUI [1,2]
    C0450429
    UMLS CUI [1,3]
    C0009758

    Similar models

    Eligibility Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma NCT01514344

    Name
    Tipo
    Description | Question | Decode (Coded Value)
    Tipo de datos
    Alias
    Item Group
    C1512693 (UMLS CUI)
    Marginal zone lymphoma | Grade 1-2 follicular lymphoma | Myeloma | Small lymphocyte lymphoma
    Item
    histological diagnosis of cd20+ b cell lymphoma subtypes: marginal zone lymphoma, grade 1-2 follicular lymphoma, plasmocytic lymphoma, small lymphocyte lymphoma
    boolean
    C1367654 (UMLS CUI [1,1])
    C0679557 (UMLS CUI [1,2])
    C0054946 (UMLS CUI [1,3])
    C0024301 (UMLS CUI [2,1])
    C0441800 (UMLS CUI [2,2])
    C0679557 (UMLS CUI [2,3])
    C0054946 (UMLS CUI [2,4])
    C0026764 (UMLS CUI [3,1])
    C0679557 (UMLS CUI [3,2])
    C0054946 (UMLS CUI [3,3])
    C0855095 (UMLS CUI [4,1])
    C0679557 (UMLS CUI [4,2])
    C0054946 (UMLS CUI [4,3])
    Conjunctival localization, stage, monolateral or bilateral
    Item
    conjunctival localization alone (1ea stage; mono- or bilateral)
    boolean
    C0475264 (UMLS CUI [1,1])
    C0009758 (UMLS CUI [1,2])
    C0443288 (UMLS CUI [1,3])
    C1300072 (UMLS CUI [1,4])
    C0238767 (UMLS CUI [1,5])
    C0475264 (UMLS CUI [2,1])
    C0009758 (UMLS CUI [2,2])
    C0443288 (UMLS CUI [2,3])
    C1300072 (UMLS CUI [2,4])
    C0205092 (UMLS CUI [2,5])
    At least one measurable lesion
    Item
    at least one measurable lesion
    boolean
    C1513041 (UMLS CUI [1,1])
    C1265611 (UMLS CUI [1,2])
    Age
    Item
    age >/= 18 years
    boolean
    C0001779 (UMLS CUI [1])
    Ecog-ps =<3
    Item
    ecog-ps </=3
    boolean
    C1520224 (UMLS CUI [1])
    HIV negative
    Item
    hiv 1-2 negativity
    boolean
    C0481430 (UMLS CUI [1])
    At least one previous treatment with antibiotic or rituximab
    Item
    at least one previous treatment (antibiotic or rituximab)
    boolean
    C0393022 (UMLS CUI [1,1])
    C2114510 (UMLS CUI [1,2])
    C1524031 (UMLS CUI [1,3])
    C0338237 (UMLS CUI [2,1])
    C2114510 (UMLS CUI [2,2])
    C1524031 (UMLS CUI [2,3])
    Item Group
    C0680251 (UMLS CUI)
    Concomitant chemotherapy | Concomitant radiation | Concomitant immunotherapy | Concomitant antibiotic therapy | Concomitant corticosteroid therapy
    Item
    concomitant conventional (chemo-, radiation, immuno-), experimental (antibiotic) or corticosteroid anticancer therapy
    boolean
    C1707479 (UMLS CUI [1,1])
    C3665472 (UMLS CUI [1,2])
    C1707479 (UMLS CUI [2,1])
    C1522449 (UMLS CUI [2,2])
    C1707479 (UMLS CUI [3,1])
    C0021083 (UMLS CUI [3,2])
    C1707479 (UMLS CUI [4,1])
    C0338237 (UMLS CUI [4,2])
    C1707479 (UMLS CUI [5,1])
    C0149783 (UMLS CUI [5,2])
    Allergy to rituximab
    Item
    known allergy to rituximab
    boolean
    C0020517 (UMLS CUI [1,1])
    C0393022 (UMLS CUI [1,2])
    Systemic symptoms
    Item
    systemic symptoms
    boolean
    C2039684 (UMLS CUI [1])
    Pemphigus as a comorbidity
    Item
    concurrent diagnosis of pemphigus
    boolean
    C0030807 (UMLS CUI [1,1])
    C0009488 (UMLS CUI [1,2])
    Postsurgical scars in conjuctival location
    Item
    postsurgical conjunctival scars
    boolean
    C0334150 (UMLS CUI [1,1])
    C0450429 (UMLS CUI [1,2])
    C0009758 (UMLS CUI [1,3])

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial